KLASSEN PRESTON (President & Head of R & D) received a stock award from REGULUS THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/10/2025ACC: 0000950170-25-004269
Officer· President & Head of R & D
Since Jun 2023
+67.50K
Net shares
Net buyer
$90.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
67.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+37.50K
Price / share
$1.36
Trade value
$51K
% of position
New position
1/9/2025
0.00→37.50K
Common Stock
Direct
Shares
+30K
Price / share
$1.30
Trade value
$39K
% of position
80.0%
1/9/2025
37.50K→67.50K
Total
Net shares
+67.50K
Net value
$90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2025 | A · Award | +37.50K | $1.36 | $51K | New position | 0.00 | 37.50K |
| Common Stock Direct | 1/9/2025 | A · Award | +30K | $1.30 | $39K | 80.0% | 37.50K | 67.50K |
| Total | +67.50K | $90K | ||||||
Derivative Transactions0
No derivative transactions reported